Related Experiment Video
Updated: Apr 23, 2026
06:45
Colon Ascendens Stent Peritonitis CASP - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
21.3K
Sustained expression of lipocalin-2 during polymicrobial sepsis
Daniel E Vazquez1, Diego F Niño2, Antonio De Maio3
1Department of Surgery, University of California San Diego, La Jolla, CA, USA.
Innate Immunity
|September 18, 2014
Summary
Lipocalin-2 (Lcn2) expression increases during polymicrobial sepsis, particularly in the liver and lungs. This antimicrobial protein may serve as a potential biomarker for sepsis diagnosis.
Area of Science:
- Immunology
- Microbiology
- Genetics
Background:
- Sepsis is a life-threatening global health issue with no reliable diagnostic methods.
- Current sepsis treatment is primarily supportive, highlighting the need for better diagnostic tools.
- The role of antimicrobial protein lipocalin-2 (Lcn2) in polymicrobial sepsis is not well understood.
Purpose of the Study:
- To investigate the role and regulation of lipocalin-2 (Lcn2) in polymicrobial sepsis.
- To explore Lcn2's potential as a diagnostic biomarker for sepsis.
Main Methods:
- Polymicrobial sepsis was induced in mice using cecal ligation and puncture (CLP).
- Lcn2 mRNA and protein levels were quantified in liver and lung tissues.
- The influence of genetic background and IL-10 on Lcn2 expression was examined in macrophages.
Main Results:
- Lipocalin-2 (Lcn2) expression was significantly induced in the liver and lungs of mice during sepsis.
- Elevated Lcn2 levels persisted during the innate immune dysfunction phase of sepsis.
- Genetic background, specifically IL-10 expression, influenced Lcn2 regulation in macrophages.
Conclusions:
- Lipocalin-2 (Lcn2) expression is tightly regulated during polymicrobial sepsis.
- Lcn2 shows potential as a biomarker for sepsis diagnosis.
- Interleukin-10 (IL-10) plays a role in regulating Lcn2 expression.
